Literature DB >> 14249395

RESPONSE TO TREATMENT WITH CHELATING AGENTS OF ANAEMIA, CHRONIC ENCEPHALOPATHY, AND MYELOPATHY DUE TO LEAD POISONING.

J A SIMPSON, D A SEATON, J F ADAMS.   

Abstract

Keywords:  ANEMIA, HEMOLYTIC; BRAIN DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; DRUG THERAPY; EDTA; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; HEMATOPOIESIS; LEAD POISONING; MUSCULAR DISEASES; NEURAL CONDUCTION; PARALYSIS; PROGNOSIS; SPINAL CORD; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14249395      PMCID： PMC495805          DOI： 10.1136/jnnp.27.6.536

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Erythrokinetic studies of the anemia of lead poisoning.

Authors:  S LEIKIN; G ENG
Journal:  Pediatrics       Date:  1963-06       Impact factor: 7.124

2.  Treatment of lead-poisoning with oral penicillamine.

Authors:  A GOLDBERG; J A SMITH; A C LOCHHEAD
Journal:  Br Med J       Date:  1963-05-11

3.  Transfer of iron from serum iron-binding protein to human reticulocytes.

Authors:  J H JANDL; J K INMAN; R L SIMMONS; D W ALLEN
Journal:  J Clin Invest       Date:  1959-01-01       Impact factor: 14.808

4.  Lead intoxication. I. The effect of lead on the in vitro biosynthesis of heme and free erythrocyte porphyrins.

Authors:  L ERIKSEN
Journal:  Scand J Clin Lab Invest       Date:  1955       Impact factor: 1.713

5.  Radioactive iron studies in routine haematological practice.

Authors:  G WETHERLEY-MEIN; M S HUTT; W A LANGMEAD; M J HILL
Journal:  Br Med J       Date:  1956-06-23

6.  Electrical signs in the diagnosis of carpal tunnel and related syndromes.

Authors:  J A SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1956-11       Impact factor: 10.154

7.  Studies on the biosynthesis of heme in vitro by avian erythrocytes.

Authors:  H ASHENBRUCKER; G E CARTWRIGHT; A GOLDBERG; M M WINTROBE
Journal:  Blood       Date:  1956-09       Impact factor: 22.113

8.  The use of the isotope 51Cr as a label for red cells.

Authors:  P L MOLLISON; N VEALL
Journal:  Br J Haematol       Date:  1955-01       Impact factor: 6.998

9.  The diagnosis and management of myelofibrosis, myelosclerosis and chronic myeloid leukaemia.

Authors:  A GOLDBERG; D A SEATON
Journal:  Clin Radiol       Date:  1960-10       Impact factor: 2.350
  9 in total
  17 in total

1.  Electrophysiology and nerve biopsy in men exposed to lead.

Authors:  F Buchthal; F Behse
Journal:  Br J Ind Med       Date:  1979-05

2.  An unusual case of lead neuropathy.

Authors:  A C Uprichard; H M Whitehead; J A Lyttle
Journal:  Ir J Med Sci       Date:  1986-05       Impact factor: 1.568

3.  Lead poisoning during heroin addiction.

Authors:  G Antonini; G Palmieri; E Millefiorini; L G Spagnoli; M Millefiorini
Journal:  Ital J Neurol Sci       Date:  1989-02

4.  Sensitive technique for detecting subclinical lead neuropathy.

Authors:  A M Seppäläinen; S Hernberg
Journal:  Br J Ind Med       Date:  1972-10

5.  Subclinical neuropathy in lead workers.

Authors:  M J Catton; M J Harrison; P M Fullerton; G Kazantzis
Journal:  Br Med J       Date:  1970-04-11

6.  [Polyneuropathy due to lead poisoning. Clinical, electrophysiological and biopsy findings].

Authors:  F Behse; J Pach; W Dorndorf
Journal:  Z Neurol       Date:  1972

7.  Chronic lead intoxication mimicking motor neurone disease.

Authors:  B Livesley; C E Sissons
Journal:  Br Med J       Date:  1968-11-09

8.  Motor neurone disease and exposure to lead.

Authors:  A M Campbell; E R Williams; D Barltrop
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

9.  An assessment of the laboratory tests used to monitor the exposure of lead workers.

Authors:  B Haeger-Aronsen
Journal:  Br J Ind Med       Date:  1971-01

10.  Trace elements in the spinal cord and other tissues in motor neuron disease.

Authors:  J D Mitchell; B W East; I A Harris; R J Prescott; B Pentland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.